Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Acquisitions (2016 - 2025)

Bruker's Acquisitions history spans 14 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Acquisitions fell 81.66% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $73.9 million, down 95.38%, while the annual FY2025 figure was $73.9 million, 95.38% down from the prior year.
  • Acquisitions reached $4.2 million in Q4 2025 per BRKRP's latest filing, up from $200000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $1.3 billion in Q2 2024 to a low of $100000.0 in Q3 2022.
  • Average Acquisitions over 5 years is $113.0 million, with a median of $20.0 million recorded in 2021.
  • Peak YoY movement for Acquisitions: skyrocketed 119500.0% in 2023, then tumbled 99.83% in 2024.
  • A 5-year view of Acquisitions shows it stood at $20.0 million in 2021, then soared by 384.0% to $96.8 million in 2022, then crashed by 95.56% to $4.3 million in 2023, then skyrocketed by 432.56% to $22.9 million in 2024, then plummeted by 81.66% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Acquisitions are $4.2 million (Q4 2025), $200000.0 (Q3 2025), and $68.4 million (Q2 2025).